Powered by

Apellis Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference

Jan 02, 2019 - GlobeNewswire
Event Announcements

CRESTWOOD, Ky., and WALTHAM Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, today announced that that it will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 4:30 p.m. Pacific Time at the Westin St. Francis in San Francisco.            

...